Skip to content

Retrolaminar Block Versus Tab Block in Abdomioasty

Comparison Between US Guided Retrolaminar Block and Transversus Abdominis Plane Block for Post Operative Analgesia in Patient Undergoing Abdominal Plastic Surgery

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06265402
Enrollment
90
Registered
2024-02-20
Start date
2024-01-15
Completion date
2025-12-15
Last updated
2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Block

Brief summary

The aim of the study is to compare the analgesic efficacy of Us guided retrolaminar block versus transversus abdominis plane block in patient under going abdominal plastic surgery

Detailed description

Pain from intra abdominal surgery is a combination of somatic and visceral pain visceral pain transmitted by autonomic nervous system via sympathetic fibers from plexuses in close proximity to the viscera them selves Regional anesthetic are commonly used to prevent or minimize these side effect the use of ultra sound nerve block are commonly use as apart of multimodal post operative analgesia The tab block is used to decrease the need of post operative analgesia in patient undergoing abdominal plastic surgery It was found an alternative approach to para vertebral block the retro laminar block is performed with us guided imaging to reduce pain post operative and need analgesia

Interventions

PROCEDURETab block versus retrolaminar block in abdominal plastic surgery

i inject 20ml bupivacine either 4mg dead in each side

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

\- 90patients aged 18/65years of both sexes and asa physical status one two and three undergoing abdominal plastic surgery

Exclusion criteria

* patient refusal Patient taking analgesia of chronic illness or have history of substance abuse Patient who are unable to describe their post operative pain Patient with history of coagulabathy Un cooperative patient Patient with known allergy to study drug Patient with infection at site needle puncture Patient with decompensated hepatic renal respiratory or cardiac disorder

Design outcomes

Primary

MeasureTime frameDescription
Total dose of morphine consumption in the first postoperative 24hoursFirst 24hoursTotal dose of morphine consumption in the first postoperative 24hours

Countries

Egypt

Contacts

Primary ContactHadeel Elsagheer, Master
Dodoelsagheer@gmail.com01090884208
Backup ContactTayseer Abdelrahman

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026